Skip to search formSkip to main contentSkip to account menu

SR 49059

Known as: SR-49059, SR49059 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

relcovaptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Untitled Eckardt Thesis by A. Sidwell
Traumatic brain injury (TBI) is a leading cause of death and disability in persons under 35 years of age. In nonfatal moderate to… 
2008
2008
バゾプレッシン-1aレセプターアンタゴニスト (SR49059) によるアクアポリン-4の調節がラットモデルにおいて外傷性脳浮腫を改善する (第125回成医会総会一般演題)
2006
2006
Functional rescue of mutant Vasopressin V2 Receptors in Nephrogenic Diabetes Insipidus : From molecular cause to restored phenotype
Mutations in G protein-coupled receptors are the cause of many inheritable disorders, including X-linked Nephrogenic Diabebetes… 
2006
2006
Protective e ¤ ect of the V 1 a receptor antagonist SR 49059 on brain edema formation following middle cerebral artery occlusion in the rat
There exists no pharmacological treatment for fulminating brain edema. Since evidence indicates that brain aquaporin-4 (AQP4… 
2002
2002
Study on Synthesis of SR49059
chlorobenzic acid, 3,4-dimethoxybenzensulphonyl chloride and L-prolinamide undergo series reactions, such as Friedel-crafts… 
2000
2000
Effect of SR49059, an orally active VIa vasopressin receptor antagonist, in the prevention of dysmenorrhoea
this hormone is increased during painful menses24. Further- more, in women who begin to experience pain before the onset of… 
2000
2000
ect of SR 49059 , a V 1 a vasopressin receptor antagonist , in Raynaud ’ s phenomenon
Objective. To assess whether vasopressin V1a receptor blockade reduces the abnormal vasoactive response to cold in patients…